Chemed Corporation (CHE) reported adjusted earnings per share (EPS) of $6.60 in the fourth quarter of 2023, up 35% year over year. The figure also surpassed the Zacks Consensus Estimate by 5.6%.The company’s GAAP EPS was $5.90, up 42.9% from last year’s reported figure. For the full year, the adjusted EPS was $20.30, reflecting an 8.1% increase from the year-ago period.Revenues in DetailRevenues in the reported quarter improved 7.2% year over year to $585.9 million. The metric missed the Zacks Consensus Est ...

Finally, the lower than anticipated hiring rate in the fourth quarter previously discussed by Kevin, provided less drag on the adjusted EBITDA margin from onboarding and training costs. Now, let's turn to Roto-Rooter. Roto-Rooter generated quarterly revenue of $235.9 million in the fourth quarter of 2023, a decrease of 1.1% when compared to the prior year quarter. Roto-Rooter branch commercial revenue in the quarter totaled $56.8 million, a decrease of 7.9% over the prior year. Roto-Rooter branch residentia ...

| --- | --- | |-------|-------------------------------------------------------------------------------------------------------------------------| | | Exhibits and Financial Statement Schedule | | 3.1 | Certificate of Incorporation of Chemed Corporation.* | | 3.2 | Certificate of Amendment to Certificate of Incorporation, dated May 15, 2006.* | | 3.3 | By-Laws of Chemed Corporation, as amended December 9, 2022* | | 4.1 | Description of Securities.* | | 10.1 | 2006 Stock Incentive Plan, as amended August 11, ...

Chemed (CHE) reported $585.91 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 7.2%. EPS of $6.60 for the same period compares to $5.39 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $587.45 million, representing a surprise of -0.26%. The company delivered an EPS surprise of +5.60%, with the consensus EPS estimate being $6.25.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Stre ...

Chemed (CHE) came out with quarterly earnings of $6.60 per share, beating the Zacks Consensus Estimate of $6.25 per share. This compares to earnings of $5.39 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 5.60%. A quarter ago, it was expected that this operator of the Roto-Rooter plumbing service and Vitas Healthcare hospices would post earnings of $4.92 per share when it actually produced earnings of $5.32, delivering a surp ...

CONTACT: Michael D. Witzeman (513) 762-6714 CINCINNATI, February 27, 2024—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2023, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed's previously reported ...

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents per share on the Company’s capital stock, payable on March 15, 2024, to shareholders of record as of February 26, 2024. This is equal to the dividend paid in December 2023. This represents the 211th consecutive quarterly dividend paid by Chemed in its 52 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio ...

Chemed Corporation (CHE) is well-poised for growth in the coming quarters, backed by the strong prospects of the VITAS Healthcare and Roto-Rooter segments. The company delivered favorable solvency as of the end of the third quarter of 2023, generating investors’ optimism. However, macroeconomic headwinds and competitive disadvantages are discouraging for the company.In the past year, this Zacks Rank #3 (Hold) stock has increased 18% compared to the 6.4% rise of the industry and a 21.2% rise of the S&P 500 c ...

Chemed Corporation (NYSE:CHE) Q3 2023 Earnings Conference Call October 26, 2023 10:00 AM ET Holley Schmidt - Assistant Controller Company Participants Kevin McNamara - President and Chief Executive Officer Dave Williams - Executive Vice President and Chief Financial Officer Nick Westfall - President and Chief Executive Officer, VITAS Healthcare Corporation Conference Call Participants Ben Hendrix - RBC Capital Markets Joanna Gajuk - Bank of America Holley Schmidt Good morning. Our conference call this morni ...

UNITED STATES (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2023 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 31-0791746 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 255 E. Fifth Street, Suite 2600, Cincin ...